Connect with us

Business

Up 300% in 1 year, what’s driving the Incannex Healthcare (ASX:IHL) share price?

Published

on

The Incannex Healthcare Ltd (ASX: IHL) share price, which has shot up 310% in the past 12 months, has remained relatively flat in today’s trade.

We take a look at the ASX healthcare share’s latest announcement on its accelerated drug study, along with its share price performance over the past year.

What did Incannex Healthcare report?

Incannex Healthcare shares are flat today after the company reported it has partnered with Monash Trauma Group to study the effectiveness of its proprietary drug on treating concussions.

The in vivo study, to be conducted on rats, will assess the “neuroprotective capability of…



Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending